AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-77
Results: 1-25/77
TREATMENT OF WALDENSTROMS-MACROGLOBULINEMIA WITH STEM-CELL TRANSPLANTATION
Authors: DREGER P GLASS B VONNEUHOFF N UHAREK L ZEIS M SCHMITZ N
Citation: P. Dreger et al., TREATMENT OF WALDENSTROMS-MACROGLOBULINEMIA WITH STEM-CELL TRANSPLANTATION, Annals of oncology, 9, 1998, pp. 524-524
ABROGATION OF GRAFT-VS.-LEUKEMIA ACTIVITY AFTER DEPLETION OF CD3(-CELLS IN A MURINE MODEL OF MHC-MATCHED PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT)() T)
Authors: UHAREK L GLASS B ZEIS M DREGER P STEINMANN J LOFFLER H SCHMITZ N
Citation: L. Uharek et al., ABROGATION OF GRAFT-VS.-LEUKEMIA ACTIVITY AFTER DEPLETION OF CD3(-CELLS IN A MURINE MODEL OF MHC-MATCHED PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPCT)() T), Experimental hematology, 26(2), 1998, pp. 93-99
ERADICATION OF RESIDUAL DISEASE BY ADMINISTRATION OF LEUKEMIA-SPECIFIC T-CELLS AFTER EXPERIMENTAL ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: ZEIS M UHAREK L GLASS B VOSSKOTTER W DREGER P SCHMITZ N STEINMANN J
Citation: M. Zeis et al., ERADICATION OF RESIDUAL DISEASE BY ADMINISTRATION OF LEUKEMIA-SPECIFIC T-CELLS AFTER EXPERIMENTAL ALLOGENEIC BONE-MARROW TRANSPLANTATION, Experimental hematology, 26(11), 1998, pp. 1068-1073
IMMUNOTHERAPEUTIC ASPECTS OF ALLOGENEIC PERIPHERAL PROGENITOR CELLS
Authors: GLASS B UHAREK L HARTUNG G ZEIS M STEINMANN J DREGER P KRONKE M SCHMITZ N
Citation: B. Glass et al., IMMUNOTHERAPEUTIC ASPECTS OF ALLOGENEIC PERIPHERAL PROGENITOR CELLS, Bone marrow transplantation, 21, 1998, pp. 3-8
SUPERIOR ANTILEUKEMIC ACTIVITY OF MURINE PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) GRAFTS MOBILIZED BY G-CSF AND STEM-CELL FACTOR (SCF) AS COMPARED TO G-CSF ALONE
Authors: HARTUNG G UHAREK L ZEIS M GLASS B STEINMANN J DREGER P KRONKE M SCHMITZ N
Citation: G. Hartung et al., SUPERIOR ANTILEUKEMIC ACTIVITY OF MURINE PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) GRAFTS MOBILIZED BY G-CSF AND STEM-CELL FACTOR (SCF) AS COMPARED TO G-CSF ALONE, Bone marrow transplantation, 21, 1998, pp. 16-20
ALLOGENEIC STEM-CELL TRANSPLANTATION AND DONOR LEUKOCYTE INFUSION IN RELAPSED HODGKINS-DISEASE
Authors: GLASS B DREGER P UHAREK L ZEIS M SCHMITZ N
Citation: B. Glass et al., ALLOGENEIC STEM-CELL TRANSPLANTATION AND DONOR LEUKOCYTE INFUSION IN RELAPSED HODGKINS-DISEASE, Bone marrow transplantation, 21, 1998, pp. 226-226
GRAFT-VERSUS-MYELOMA (GVM) EFFECTS AFTER INDUCTION OF IDIOTYPE-SPECIFIC IMMUNITY IN MURINE STEM-CELL DONORS
Authors: ZEIS M UHAREK L PETRELLA E GLASS B STEINMANN J SCHMITZ N
Citation: M. Zeis et al., GRAFT-VERSUS-MYELOMA (GVM) EFFECTS AFTER INDUCTION OF IDIOTYPE-SPECIFIC IMMUNITY IN MURINE STEM-CELL DONORS, Bone marrow transplantation, 21, 1998, pp. 239-239
TRANSFER OF TH2 POLARIZED CD4-CELLS FOR THE INDUCTION OF GRAFT-VERSUS-LEUKEMIA EFFECTS AFTER STEM-CELL TRANSPLANTATION( DONOR T)
Authors: UHAREK L ZEIS M HARTUNG G GLASS B DREGER P STEINMANN J SCHMITZ N
Citation: L. Uharek et al., TRANSFER OF TH2 POLARIZED CD4-CELLS FOR THE INDUCTION OF GRAFT-VERSUS-LEUKEMIA EFFECTS AFTER STEM-CELL TRANSPLANTATION( DONOR T), Bone marrow transplantation, 21, 1998, pp. 240-240
STEM-CELL TRANSPLANTATION FOR CLL - FACTORS DETERMINING THE FEASIBILITY OF HIGH-DOSE THERAPY
Authors: DREGER P SCHOCH R SONNEN R KUSE R VIEHMANN K GLASS B UHAREK L SCHMITZ N
Citation: P. Dreger et al., STEM-CELL TRANSPLANTATION FOR CLL - FACTORS DETERMINING THE FEASIBILITY OF HIGH-DOSE THERAPY, Bone marrow transplantation, 21, 1998, pp. 279-279
TREATMENT OF MANTLE CELL LYMPHOMA WITH SEQUENTIAL HIGH-DOSE THERAPY AND STEM-CELL TRANSPLANTATION
Authors: DREGER P HELD H SONNEN R KUSE R GLASS B UHAREK L ZEIS M VONNEUHOFF N SUTTORP M SCHMITZ N
Citation: P. Dreger et al., TREATMENT OF MANTLE CELL LYMPHOMA WITH SEQUENTIAL HIGH-DOSE THERAPY AND STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 583-583
COMPLETE DEPLETION OF T-EFFECTOR CELLS FROM PBSC IS FEASIBLE AND DOESNOT AFFECT ENGRAFTMENT
Authors: DREGER P GLASS B UHAREK L SUTTORP M VIEHMANN K SCHOCH R ZEIS M SCHMITZ N
Citation: P. Dreger et al., COMPLETE DEPLETION OF T-EFFECTOR CELLS FROM PBSC IS FEASIBLE AND DOESNOT AFFECT ENGRAFTMENT, British Journal of Haematology, 102(1), 1998, pp. 78-78
GRAFT-VERSUS-MYELOMA (GVM) EFFECTS AFTER INDUCTION OF IDIOTYPE-SPECIFIC IMMUNE REACTIVITY IN ALLOGENEIC MURINE STEM-CELL DONORS
Authors: UHAREK L ZEIS M PETRELLA E GLASS B STEINMANN J KRONKE M SCHMITZ N
Citation: L. Uharek et al., GRAFT-VERSUS-MYELOMA (GVM) EFFECTS AFTER INDUCTION OF IDIOTYPE-SPECIFIC IMMUNE REACTIVITY IN ALLOGENEIC MURINE STEM-CELL DONORS, British Journal of Haematology, 102(1), 1998, pp. 83-83
APOPTOSIS AND CYTOLYSIS INDUCED BY CYTOKINE-ACTIVATED ALLOGENEIC NK CELLS IN WILD-TYPE LEUKEMIA-CELLS
Authors: GLASS B SCHLEMMINGER S UHAREK L LEHMANN C ZEIS M STEINMANN J KRONKE M SCHMITZ N
Citation: B. Glass et al., APOPTOSIS AND CYTOLYSIS INDUCED BY CYTOKINE-ACTIVATED ALLOGENEIC NK CELLS IN WILD-TYPE LEUKEMIA-CELLS, British Journal of Haematology, 102(1), 1998, pp. 84-84
RESISTANCE TO CONVENTIONAL CHEMOTHERAPY AT ANY TIME IN THE COURSE OF DISEASE IS A NEW RISK FACTOR FOR PATIENTS AUTOGRAFTED WITH RELAPSED HODGKINS-DISEASE
Authors: GLASS B KLOESS M DREGER P UHAREK L ZEIS M LOEFLER M SCHMITZ N
Citation: B. Glass et al., RESISTANCE TO CONVENTIONAL CHEMOTHERAPY AT ANY TIME IN THE COURSE OF DISEASE IS A NEW RISK FACTOR FOR PATIENTS AUTOGRAFTED WITH RELAPSED HODGKINS-DISEASE, British Journal of Haematology, 102(1), 1998, pp. 151-151
INDUCTION OF ANTITUMOR IMMUNITY BY IDIOTYPE-PULSED DENDRITIC CELLS AGAINST ESTABLISHED MULTIPLE-MYELOMA
Authors: ZEIS M UHAREK L GLASS B KRONKE M STEINMANN J SCHMITZ N
Citation: M. Zeis et al., INDUCTION OF ANTITUMOR IMMUNITY BY IDIOTYPE-PULSED DENDRITIC CELLS AGAINST ESTABLISHED MULTIPLE-MYELOMA, British Journal of Haematology, 102(1), 1998, pp. 286-287
MECHANISMS OF TARGET-CELL RESISTANCE AGAINST THE INDUCTION OF CYTOLYTIC CELL-DEATH BY NATIVE AND IL12 IL2-ACTIVATED NATURAL-KILLER-CELLS/
Authors: LEHMANN C UHAREK L ZEIS M GLASS B KRONKE M SCHMITZ N
Citation: C. Lehmann et al., MECHANISMS OF TARGET-CELL RESISTANCE AGAINST THE INDUCTION OF CYTOLYTIC CELL-DEATH BY NATIVE AND IL12 IL2-ACTIVATED NATURAL-KILLER-CELLS/, British Journal of Haematology, 102(1), 1998, pp. 286-286
EARLY STEM-CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - A CHANCE FOR CURE
Authors: DREGER P VONNEUHOFF N KUSE R SONNEN R GLASS B UHAREK L SCHOCH R LOFFLER H SCHMITZ N
Citation: P. Dreger et al., EARLY STEM-CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - A CHANCE FOR CURE, British Journal of Cancer, 77(12), 1998, pp. 2291-2297
MANAGEMENT OF INFECTIONS DURING INTENSIVE TREATMENT OF HEMATOLOGIC MALIGNANCIES
Authors: MASCHMEYER G HIDDEMANN W LINK H CORNELY OA BUCHHEIDT D GLASS B ADAM D
Citation: G. Maschmeyer et al., MANAGEMENT OF INFECTIONS DURING INTENSIVE TREATMENT OF HEMATOLOGIC MALIGNANCIES, Annals of hematology, 75(1-2), 1997, pp. 9-16
ALLOGENIC TRANSPLANTATION OF MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS - TOWARDS TAILORED CELL THERAPY
Authors: DREGER P GLASS B UHAREK L ZEIS M SCHMITZ N
Citation: P. Dreger et al., ALLOGENIC TRANSPLANTATION OF MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS - TOWARDS TAILORED CELL THERAPY, International journal of hematology, 66(1), 1997, pp. 1-11
SEQUENTIAL HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATIONFOR TREATMENT OF MANTLE CELL LYMPHOMA
Authors: DREGER P VONNEUHOFF N KUSE R SONNEN R GLASS B UHAREK L BARTELS H LOFFLER H SCHMITZ N
Citation: P. Dreger et al., SEQUENTIAL HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATIONFOR TREATMENT OF MANTLE CELL LYMPHOMA, Annals of oncology, 8(4), 1997, pp. 401-403
SUPERIOR GRAFT-VERSUS-LEUKEMIA ACTIVITY AFTER TRANSPLANTATION OF PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) GRAFTS MOBILIZED BY G-CSF AND SCF COMPARED TO G-CSF ALONE
Authors: UHAREK L HARTUNG G ZEIS M GLASS B SCHMITZ N
Citation: L. Uharek et al., SUPERIOR GRAFT-VERSUS-LEUKEMIA ACTIVITY AFTER TRANSPLANTATION OF PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) GRAFTS MOBILIZED BY G-CSF AND SCF COMPARED TO G-CSF ALONE, Experimental hematology, 25(8), 1997, pp. 207-207
LYSIS OF NK-RESISTANT LEUKEMIA, LYMPHOMA AND MULTIPLE-MYELOMA CELLS BY ALLOGENEIC CD56-2 AND IL-12( LYMPHOCYTES ACTIVATED WITH IL)
Authors: LEHMANN C UHAREK L ZEIS M GLASS B STEINMANN J SCHMITZ N
Citation: C. Lehmann et al., LYSIS OF NK-RESISTANT LEUKEMIA, LYMPHOMA AND MULTIPLE-MYELOMA CELLS BY ALLOGENEIC CD56-2 AND IL-12( LYMPHOCYTES ACTIVATED WITH IL), Experimental hematology, 25(8), 1997, pp. 556-556
INFLUENCE OF ALLOGENEIC TH-1 AND TH-2 TYPE CD4-CELLS ON GRAFT-VERSUS-HOST DISEASE AND GRAFT-VERSUS-LEUKEMIA (GVL) EFFECTS IN MICE( T)
Authors: ZEIS M UHAREK L GLASS B DREGER P STEINMANN J SCHMITZ N
Citation: M. Zeis et al., INFLUENCE OF ALLOGENEIC TH-1 AND TH-2 TYPE CD4-CELLS ON GRAFT-VERSUS-HOST DISEASE AND GRAFT-VERSUS-LEUKEMIA (GVL) EFFECTS IN MICE( T), Experimental hematology, 25(8), 1997, pp. 562-562
ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR CELLS FOR TREATMENT OF RELAPSEAFTER BONE-MARROW TRANSPLANTATION
Authors: GLASS B MAJOLINO I DREGER P SCIME R SANTORO A VASTA S SUTTORP M HAFERLACH T SCHMITZ N
Citation: B. Glass et al., ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR CELLS FOR TREATMENT OF RELAPSEAFTER BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 20(7), 1997, pp. 533-541
REGULATION OF PPAR-ALPHA FUNCTION BY DIETARY PHYTANIC ACID IN NORMAL AND SEP ALPHA-DEFICIENT MICE
Authors: SEEDORF U ELLINGHAUS P GLASS B ASSMANN G
Citation: U. Seedorf et al., REGULATION OF PPAR-ALPHA FUNCTION BY DIETARY PHYTANIC ACID IN NORMAL AND SEP ALPHA-DEFICIENT MICE, Circulation, 96(8), 1997, pp. 3700-3700
Risultati: 1-25 | 26-50 | 51-75 | 76-77